Evidence map›Paper›PMID 25309932›Full record

ReviewJournal of immunology research2014

The central role of the gut microbiota in chronic inflammatory diseases.

Caroline Marcantonio Ferreira, Angélica Thomaz Vieira, Marco Aurelio Ramirez Vinolo, Fernando A Oliveira, Rui Curi, Flaviano dos Santos Martins

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of immunology research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06449170 (BIAMEX), which is not on this map. Cited by 106 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06449170 naunknown statusnot on this mapstarted 2023, after this paper: background citation

BIAMEX: Discovery of Biomarkers of Intake of Highly Consumed Foods in Mexico by Untargeted Metabolomics

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2023 to 2024Enrolled12ConditionsNutrition, Healthy, Diet Habit, Diet, Healthy, Dietary ExposureArmsMango Ataulfo, Avocado Hass, Nopal, 3 corn tortilla, Guava
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caroline Marcantonio FerreiraDepartment of Pharmacology, Institute of Biomedical Sciences, ICB-1, Sao Paulo University, 05508-000 São Paulo, SP, Brazil.
Angélica Thomaz VieiraDepartment of Genetics, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil.
Marco Aurelio Ramirez VinoloDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas, 13083-970 Campinas, SP, Brazil.
Fernando A OliveiraDepartment of Biological Sciences, Section of Physiology and Pharmacology, Federal University of Sao Paulo, 09913-030 Diadema, SP, Brazil.
Rui CuriDepartment of Physiology and Biophysics, Institute of Biomedical Sciences, ICB-1, Sao Paulo University, 05508-000 São Paulo, SP, Brazil.
Flaviano dos Santos MartinsDepartment of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commensal microbiota is in constant interaction with the immune system, teaching immune cells to respond to antigens. Studies in mice have demonstrated that manipulation of the intestinal microbiota alters host immune cell homeostasis. Additionally, metagenomic-sequencing analysis has revealed alterations in intestinal microbiota in patients suffering from inflammatory bowel disease, asthma, and obesity. Perturbations in the microbiota composition result in a deficient immune response and impaired tolerance to commensal microorganisms. Due to altered microbiota composition which is associated to some inflammatory diseases, several strategies, such as the administration of probiotics, diet, and antibiotic usage, have been utilized to prevent or ameliorate chronic inflammatory diseases. The purpose of this review is to present and discuss recent evidence showing that the gut microbiota controls immune system function and onset, development, and resolution of some common inflammatory diseases.

Indexed as

Chronic DiseaseGastrointestinal TractHumansImmune SystemInflammatory Bowel DiseasesIntestinal MucosaMicrobiotaModels, Immunological

Identifiers

PMID25309932
PMCPMC4189530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.